Delta 9 Cannabis Inc. (DLTNF)
Delta 9 Cannabis Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Winnipeg, MB, CA. The stock last traded at $0.01, down 1.95% on the session, giving a market capitalisation of $3.0M. On trailing twelve-month figures it carries a trailing P/E of -0.05, a net margin of -24.6%. Its beta of 1.13 implies it has historically moved more than the broad market.
Delta 9 Cannabis Inc. is a comprehensive, integrated enterprise within the cannabis sector. Leveraging its subsidiary, Delta 9 Bio-Tech Inc., the company covers the entire vertical spectrum of the cannabis supply chain. This includes everything from cultivation and processing to extraction, wholesale distribution, and ultimately, the retail sale of both medical and recreational cannabis offerings. Its product portfolio encompasses a diverse range of items, including classic dried cannabis flower, convenient pre-rolls, and dried sift, alongside more specialized offerings like decontamination pods. The company also manufactures various oils and other extracted or derivative cannabis products. Beyond consumer products, Delta 9 extends its services to other industry participants, providing grow pods and live cannabis plants to both licensed and pre-licensed businesses. Furthermore, Delta 9 operates a medical clinic, offering physician consultations to patients who require a medical recommendation to obtain a cannabis prescription. Its retail presence is substantial, with 35 stores operating under the "Delta 9" brand across the Canadian Prairies as of April 20, 2022. Established in 2001, Delta 9 Cannabis Inc. maintains its headquarters in Winnipeg, Canada.
Delta 9 Cannabis Inc. is most often compared with the following Healthcare names: